iBio CDMO Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • 2ndary - Private

iBio CDMO General Information

Description

Developer of novel therapeutic proteins and vaccines designed to commercialize and improve outcomes for patients with cancer and other diseases. The company's therapeutic proteins and vaccines developed through its technology platform, thereby enabling medical practitioners to create treatments with increased safety and effectiveness while reducing both costs and development time.

Contact Information

Website
www.ibiocmo.com
Formerly Known As
iBio CMO, Caliber Biotherapeutics
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • CDMO Facility
  • 8800 HSC Parkway
  • Bryan, TX 77807
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
IBio
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • CDMO Facility
  • 8800 HSC Parkway
  • Bryan, TX 77807
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

iBio CDMO Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 23-Feb-2017 Completed Generating Revenue
4. Secondary Transaction - Private 13-Jan-2016 0000 0000 Completed Generating Revenue
3. Merger/Acquisition 31-Dec-2015 Completed Generating Revenue
2. Grant 01-Jan-2011 $52.8M Completed Generating Revenue
1. PE Growth/Expansion Completed Generating Revenue
To view iBio CDMO’s complete valuation and funding history, request access »

iBio CDMO Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cancer Prevention and Research Institute of Texas Government 000 0000 000000 0
Defense Advanced Research Projects Agency Government 000 0000 000000 0
Eastern Capital (Pakistan) Venture Capital Minority 000 0000 000000 0
G-Con Manufacturing PE-Backed Company Majority 000 0000 000000 0
MedCare Investment Funds PE/Buyout Minority 000 0000 000000 0
To view iBio CDMO’s complete investors history, request access »

iBio CDMO Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Valor Biotherapeutics 13-Nov-2012 00000 0000 Biotechnology
To view iBio CDMO’s complete investments history, request access »

Ready to get started?

Request a free trial

iBio CDMO Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
Valor Biotherapeutics 13-Nov-2012 00000 000000 Completed
  • 2 buyers
To view iBio CDMO’s complete exits history, request access »

iBio CDMO FAQs

  • When was iBio CDMO founded?

    iBio CDMO was founded in 2009.

  • Who is the founder of iBio CDMO?

    David Shanahan is the founder of iBio CDMO.

  • Where is iBio CDMO headquartered?

    iBio CDMO is headquartered in Bryan, TX.

  • What industry is iBio CDMO in?

    iBio CDMO’s primary industry is Biotechnology.

  • Is iBio CDMO a private or public company?

    iBio CDMO is a Private company.

  • What is iBio CDMO’s current revenue?

    The current revenue for iBio CDMO is 00000.

  • Who are iBio CDMO’s investors?

    Cancer Prevention and Research Institute of Texas, Defense Advanced Research Projects Agency, Eastern Capital (Pakistan), G-Con Manufacturing, and MedCare Investment Funds have invested in iBio CDMO.

  • When was iBio CDMO acquired?

    iBio CDMO was acquired on 23-Feb-2017.

  • Who acquired iBio CDMO?

    iBio CDMO was acquired by IBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »